Genentech Inc. (NYSE: DNA) accepted a $95 a share offer from Swiss pharmaceutical giant Roche in a $46.8 billion deal. The stock price climbed $1.86 to $94.03.
Roche To Acquire Genentech
March 12, 2009 at 14:28 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.